Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 October 2020

New Respiratory Disease Articles from our Partners at Consultant 360

Genotype-Based Asthma Treatment Improves Outcomes 

A recent study was the first to examine the personalization of asthma care in children based on genetic characteristics compared with usual treatment methods. 

https://www.consultant360.com/exclusive/pulmonology/asthma/genotype-based-asthma-treatment-improves-outcomes 

Which Patients Struggle the Most With Inhaler Use?

In a new study, researchers assessed inhaler use among patients with COPD and asthma, and assessed which inhaler attributes were most important to users.

https://www.consultant360.com/exclusive/pulmonology/copd/which-patients-struggle-most-inhaler-use

CASE REPORT/SLIDESHOW: A Collection of Conditions Affecting the Lungs

This article collects 3 photo-based case reports about conditions affecting the lungs, including large pulmonary embolus with unilateral hyperlucent lung, atelectasis, and Streptococcus pneumoniae phlegmon.

https://www.consultant360.com/articles/collection-conditions-affecting-lungs-0 

FEATURE ARTICLE/PEER REVIEWED: The Perils of Prednisone

Prednisone is a prodrug. Prednisone is a glucocorticoid. Prednisone is a mineralocorticoid. But is prednisone a poison? What have patients taught us about prednisone? 

https://www.consultant360.com/article/pulmonology/asthma/perils-prednisone 

Q&A 4 Questions About Mucin Abnormalities in Early COPD

In this Q&A, Mehmet Kesimer, PhD, answers our questions about the potential for mucin abnormalities to help identify patients who are at risk for progressing to severe COPD.
https://www.consultant360.com/exclusive/pulmonology/ats/4-questions-about-mucin-abnormalities-early-copd